drugset / Trial / NCT00042900

Pyroxamide in Treating Patients With Advanced Cancer

NCT00042900 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of pyroxamide in treating patients who have advanced cancer.

Timeline

Start
2002-04
Primary completion
2002-09
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject pyroxamide Small molecule — Intravenous